This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Molina Healthcare (MOH) Misses on Q2 Earnings, Hikes '21 View
by Zacks Equity Research
Molina Healthcare's (MOH) Q2 earnings suffer escalating expenses. However, the same was partly offset by improved revenues and better membership.
Humana's (HUM) Q2 Earnings Surpass Estimates, Tumble Y/Y
by Zacks Equity Research
Humana's (HUM) second-quarter earnings gain from higher revenues and strong performances by its Retail and Healthcare Services segments.
Encompass Health (EHC) Beats on Q2 Earnings, Hikes '21 View
by Zacks Equity Research
Encompass Health's (EHC) second-quarter results highlight growing revenues stemming from strong segmental performances, partly offset by elevated costs.
Centene's (CNC) Q2 Earnings Miss Estimates, Improve Y/Y
by Zacks Equity Research
Centene's (CNC) second-quarter earnings gain from better revenues and membership growth.
Tenet Healthcare (THC) Beats on Q2 Earnings, Ups '21 EPS View
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter results gain on the back of higher revenues, and well-performing Hospital, Ambulatory and Conifer segments, partly offset by escalating costs.
Tenet Healthcare (THC) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 45.87% and 3.80%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Tenet Healthcare (THC) Q2 Earnings Expected to Decline
by Zacks Equity Research
Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold on to Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna (CI) is currently riding on solid top-line growth, expanding global presence and prudent capital deployment.
HCA Healthcare (HCA) Buys 80% Stake in BHS, Boosts Network
by Zacks Equity Research
HCA Healthcare (HCA) completes purchase of majority stake in Brookdale's BHS, which has added around 80 care sites to the former's portfolio enabling it to offer enhanced healthcare services.
Zacks Industry Outlook Highlights: HCA Healthcare, Universal Health Services, Tenet Healthcare and Acadia Healthcare
by Zacks Equity Research
Zacks Industry Outlook Highlights: HCA Healthcare, Universal Health Services, Tenet Healthcare and Acadia Healthcare
Why Should You Hold HCA Healthcare (HCA) in Your Portfolio?
by Zacks Equity Research
Riding high on growth measures and a solid 2021 guidance, HCA Healthcare (HCA) holds enough potential to reap benefits for investors.
4 Hospital Stocks to Gain From Rising Admissions, Aging Demography
by Zacks Equity Research
Expanding patient volumes, use of telehealth services, cost-control efforts and an aging demography are tailwinds to the hospital industry.
Here's Why You Should Hold on to Universal Health (UHS) Now
by Zacks Equity Research
Banking on its Acute Care and Behavioral Health platforms along with a robust capital position, Universal Health (UHS) holds potential to reap benefits for investors.
Tenet (THC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Tenet (THC) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tenet (THC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Tenet Healthcare (THC) to Divest Hospitals for $1.1 Billion
by Zacks Equity Research
Tenet Healthcare (THC) to sell five hospitals to Steward Health Care System, LC for a deal value of $1.1 billion.
Are You Looking for a Top Momentum Pick? Why Tenet Healthcare (THC) is a Great Choice
by Zacks Equity Research
Does Tenet Healthcare (THC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Tenet Healthcare (THC) Soars 69% YTD: More Room to Run?
by Zacks Equity Research
Banking high on a solid guidance and strategic measures, Tenet Healthcare (THC) holds enough potential to reap benefits for investors.
Zacks Industry Outlook Highlights: Tenet Healthcare, Universal Health Services, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
Zacks Industry Outlook Highlights: Tenet Healthcare, Universal Health Services, Acadia Healthcare and Community Health Systems
3 Stocks to Watch as Hospital Industry Stages a Recovery
by Zacks Equity Research
Strategic buyouts, divestitures, better volumes and cost-cutting measures are expected to aid hospital companies like ACHC, THC and CYH.
Community Health (CYH) Soars 111% YTD: More Room to Run?
by Zacks Equity Research
Community Health's (CYH) strategic initiatives are likely to boost its revenues, which in turn, might perk up its share price.
Ensign Group (ENSG) Boosts Washington Presence With Health Hubs
by Zacks Equity Research
Ensign Group (ENSG) acquires four skilled nursing facilities in Washington. The move intends to offer improved health outcomes across the state.
Encompass Health (EHC) Buys Frontier, Boosts Home Health Services
by Zacks Equity Research
Encompass Health (EHC) completes the purchase of Frontier, which reflects its efforts to offer enhanced care across several states.
Here's Why You Should Retain Acadia Healthcare (ACHC) Stock
by Zacks Equity Research
Acadia Healthcare (ACHC) is gaining from rise in revenues, several acquisitions and joint ventures as well as robust cash flows.
Encompass Health (EHC) Gains on Strong Revenues & Cash Flows
by Zacks Equity Research
Encompass Health (EHC) set to benefit on the back of consistent top-line growth, robust 2021 business outlook and strong liquidity stand.